Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

EXCLUSIVE: MariMed CEO Discusses Evolving Illinois Cannabis Market, Rescheduling

Published 28/09/2023, 14:23
© Reuters.  EXCLUSIVE: MariMed CEO Discusses Evolving Illinois Cannabis Market, Rescheduling

Benzinga - by Nicolás Jose Rodriguez, Benzinga Staff Writer.

Jon Levine, CEO of multi-state cannabis operator, MariMed (OTC: MRMD), and Erik Sloane, Global Head of Corporate Listings at Cboe Canada, discussed the evolving Illinois cannabis market at the Benzinga Cannabis Capital Conference.

Levine noted their strong management team, emphasizing their experience and commitment to building a consistent brand. He acknowledged increased competition in Illinois due to more dispensaries and neighboring states like Missouri entering the market.

However, he remained confident in MariMed's brand strength and quality. "Our stock is undervalued compared to competitors," Levine said

Want to watch Benzinga's Cannabis Capital Conference live? For existing subscribers, get direct access through our research platform. For new users, you can get instant access here!

Rescheduling Cannabis The panel also discussed the potential impact of rescheduling cannabis.

Rescheduling, more than safe banking, would significantly benefit the industry by reducing taxes and promoting profitability, Levine said.

"Rescheduling is more important than safe banking. It will make it stronger for people to get into this business," Levine said.

The CEO also highlighted MariMed's disciplined approach to growth, focusing on cash flow and profitability, making them an attractive option for investors.

Sloane mentioned the potential for institutional investment and stock exchange listings, which could stabilize the industry and reduce retail investor-driven volatility. Meanwhile, Levine encouraged investors to consider MariMed's financials, stating their stock is undervalued compared to competitors.

Want to watch more about the cannabis bill and what it means for the industry? Tune in to the Benzinga Cannabis Capital Conference in Chicago live. For existing subscribers, you can get direct access through our research platform. For new users, you can get instant access here!

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Photo by Sawyer Bengtson on Unsplash.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.